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368A Percutaneous Treatment Algorithm for Crossing Coronary
Chronic Total Occlusions
Coronary chronic total occlusions (CTOs) are frequently identiﬁed during coronary angiography and remain the most challeng-
ing lesion group to treat. Patients with CTOs are frequently left unrevascularized due to perceptions of high failure rates and
technical complexity even if they have symptoms of coronary disease or ischemia. In this review, the authors describe a North
American contemporary approach for percutaneous coronary interventions for CTO. Two guide catheters are placed to facilitate
seamless transition between antegrade wire–based, antegrade dissection re-entry–based, and retrograde (wire or dissection
re-entry) techniques, the “hybrid” interventional strategy. After dual coronary injection is performed, 4 angiographic parameters
are assessed: 1) clear understanding of location of the proximal cap using angiography or intravascular ultrasonography; 2) le-
sion length; 3) presence of branches, as well as size and quality of the target vessel at the distal cap; and 4) suitability of collat-
erals for retrograde techniques. On the basis of these 4 characteristics, an initial strategy and rank order hierarchy for technical
approaches is established. Radiation exposure, contrast utilization, and procedure time are monitored throughout the proce-
dure, and thresholds are established for intraprocedural strategy conversion to maximize safety, efﬁciency, and
effectiveness. (J Am Coll Cardiol Intv 2012;5:367–79) © 2012 by the American College of Cardiology Foundationt
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MPercutaneous coronary intervention (PCI) of coronary
chronic total occlusions (CTOs) has historically been lim-
ited by technical success rates of 50% to 70%, despite
being performed in highly selected cases (1–4). In the
current era, however, operators and programs with higher
CTO PCI–specific experience and modern techniques and
technologies can consistently achieve technical success rates
of 80% in a more unselected and complex population of
CTO patients, as has been reported in Europe (5), Japan
(6), the United States (7), and Canada (8). Although there
are multiple reports on techniques that can result in
successful CTO PCI, there is little published information
on how these techniques can be used together, as part of
a comprehensive procedural strategy. The goal of the
present report is to propose an algorithmic approach to
CTO PCI, in an attempt to demystify the field and create
common ground among operators who are currently
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program. The approach presented herein is based on the
expert opinion of 13 high-volume North American CTO
operators. The purpose of this proposed algorithm is to
provide a consistent framework that can be used to
evaluate patients considered for CTO PCI and provide a
reproducible and teachable method to expand a base of
interventionalists that perform safe, effective, and effi-
cient CTO PCI.
Fundamentals and the Learning Curve
The current paper presupposes that experience with the
requisite techniques and technologies has been established
before applying the following algorithms. During the learn-
ing phase for CTO operators and CTO programs, these
experiences may be more compartmentalized to certain
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369strategies, as there is often safety and technical equipoise
between approaches. We recognize that it is not reasonable
to propose algorithms that weigh toward methods that have
not been accessible or employed by the emerging operators.
Lifetime non-CTO PCI experience, although helpful, does
not immediately translate to better CTO PCI techniques, as
these techniques, wires, and devices are often employed in a
manner that is counterintuitive to the standard PCI proce-
dure. To this end, we strongly recommend local proctoring
program and attendance at local and national CTO focused
meetings to develop the didactic and clinical skill sets
required for advanced CTO PCI. Although this paper
cannot alleviate the need for proper proctorship of new
CTO operators, it summarizes information often transmit-
ted in teaching sessions in an organized manner. As the CTO
PCI operator becomes more confident with wire selection,
shaping, manipulation, device utilization, and advanced tech-
niques (e.g., retrograde and antegrade re-entry techniques), a
reasonable transition can occur to employ the following algo-
rithms to optimize the CTO procedures in terms of efficiency,
safety, and effectiveness. The learning curve and applications of
the algorithms, however, need not be mutually exclusive in the
proctored environment because the patient’s anatomy will
dictate strategies.
Indications for CTO PCI
A detailed, in-depth clinical assessment is critical before
proceeding with CTO PCI. CTO PCI should only be
performed if it carries a favorable risk/benefit ratio. CTO
PCI can provide angina relief (9), improve exercise tolerance
(10) and left ventricular function (11), improve tolerance of
a future acute coronary syndrome (12), reduce the need for
coronary artery bypass graft surgery (13), and possibly improve
survival if successful (especially for PCI of left anterior de-
scending artery CTOs) (2,14). Moreover, CTO PCI carries
similar risk to non-CTO PCI (1). As with any type of coronary
revascularization, CTO PCI will mostly benefit patients who
have angina refractory to optimal medical management (15)
and those with large ischemic burden.
Pre-Procedure Angiographic Review, Arterial
Access, and the Role of Dual Selective
Angiography for CTO PCI
Careful study of the target CTO lesion cannot be overem-
phasized: 20 min of pre-procedure review of the angiogram
is often required to fully understand the CTO anatomy and
collateral circulation. We discourage routine “ad hoc” CTO
PCI because pre-planning facilitates a thoughtful proce-
dural approach and estimation of the risk–benefit ratio in
this complex lesion/patient subset. Understanding the vessel
course and the presence, quality, and location of collateral
vessels can allow rapid adjustments and change of strategiesduring the procedure and maximizes the likelihood of
procedural success.
In the current report, we advocate a routine 2 guide
catheter strategy, with a shortened (90 cm long) catheter
in the retrograde vessel to allow for seamless, efficient
transition between antegrade and retrograde techniques in
eligible patients. Long (35 to 45 cm) sheaths and large-bore
guide catheters (7- to 8-F) are preferred for providing
additional support and options, although experienced tran-
sradial operators can successfully perform CTO using
smaller 6-F catheters (8). Dual arterial access is commonly
used (bifemoral, biradial, femoral–radial). Alternative meth-
ods to augment guide catheter support include “mother and
child” extensions, such as the GuideLiner catheter (Vascular
Solutions, Minneapolis, Minnesota) (16) and various
balloon anchoring techniques (17–19).
Dual injection is critical for performing CTO PCI and
should be performed in every case where contralateral
collaterals exist (20). Nonsimultaneous, single-catheter in-
jection frequently provides suboptimal visualization of the
CTO segment and limited abil-
ity to assess the proximal and
distal caps, and distal vessel be-
yond the CTO, due to collateral
competitive flow. In addition,
single-catheter antegrade injection
during dissection/re-entry tech-
niques may result in hydraulic en-
largement of the subintimal space
and reduce the chances of successful
re-entry. Filling the collateral bed
with dual injection reduces non-
contrast-containing competitive
flow and provides optimal visualiza-
tion of the CTO vessel. Furthermore, the collateral flow direction
and strength of flow can shift from 1 source to another during the
course of a procedure, likely due to collateral compromise as well
as potential activation of vasoactive substances during intervention.
Dual injection is performed through selective coronary
angiography from the CTO PCI target vessel and through
another vessel (the contralateral coronary artery or a bypass
graft) that provides collaterals to the distal target vessel.
Dual injection is crucial for determining the lesion length
and the size and location of the distal target vessel, evalu-
ating whether there is a significant bifurcation at the distal
cap, and for deciding on the optimal CTO PCI strategy
(20). Occasionally, dual injection will reveal that the “CTO”
may actually not be a total occlusion, but rather a “func-
tional” occlusion with a central patent microchannel. Dual
injection can reveal the presence, size, and tortuosity of
collateral vessels and help determine whether a retrograde
approach is feasible. Dual injection is also critical for
clarifying the location of the angioplasty wire or other
Abbreviations
and Acronyms
CART  controlled
antegrade and retrograde
tracking
CTO  chronic total
occlusion
LaST  limited antegrade
subintimal tracking
OTW  over the wire
PCI  percutaneous
coronary intervention
RAO  right anterior obliqueequipment during CTO crossing attempts.
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370Dual injection is best performed at low magnification,
with prolonged imaging exposure, and without table pan-
ning, to allow for optimal delineation of the CTO segment
and collateral vessel location and course. To minimize
radiation exposure, the donor vessel (vessel that supplies the
territory distal to the CTO) is injected first, followed by
injection of the occluded vessel (20). Bridging collaterals are
important to recognize and avoid during both antegrade and
retrograde crossing attempts to minimize the risk of vessel
perforation, especially when advancing microcatheters and
balloons. Septal collaterals are best visualized from a right
anterior oblique (RAO) cranial view, or straight RAO view,
whether the donor vessel is the posterior descending coro-
nary artery or the left anterior descending coronary artery.
Epicardial collaterals often need tailored views to assess
their course, as they are often from diagonal, left circumflex,
and right coronary posterolateral territories; the left anterior
oblique and RAO cranial views are often the best to image
distal lateral wall collaterals between obtuse marginal arter-
ies and posterolateral arteries and diagonal to diagonal/
obtuse marginal connections; and the RAO and anteropos-
terior caudal views are preferred for collaterals connecting
the more proximal obtuse marginal arteries and those arising
in the atrioventricular groove between the circumflex and
right coronary arteries.
In patients with only ipsilateral collaterals, dual arterial
access and dual injection may not be required, although in
some cases, contralateral collaterals may appear if ipsilateral
collaterals are compromised during CTO crossing attempts.
Moreover, 2 guide catheters may be required if retrograde
CTO crossing is performed via ipsilateral collaterals: 1 guide
catheter is used to advance the retrograde guidewire, and a
second one is used for externalizing the retrograde guide-
wire and/or antegrade wiring. Engagement of the target
coronary artery is alternating between the antegrade and the
retrograde guide catheter in a “ping-pong” fashion, enabling
lesion crossing and equipment delivery (21).
The “Base of Operations”
The first goal of the proposed algorithm is to safely and
efficiently establish guidewire and microcatheter position in
the lesion segment known as the “base of operations.” The
purpose is to spend procedure time, radiation, and contrast
focused on final recanalization of a short, isolated segment.
The base of operations is typically at or near the distal cap
for the antegrade direction and at or near the proximal cap
for retrograde direction procedures. It is important to realize
that this effective working segment may need to be shifted
to a different location within the vessel, for example, beyond
the distal cap for re-entry, or elsewhere in the CTO
segment for controlled antegrade retrograde tracking
(CART), reverse CART, and limited antegrade subintimal
tracking (LaST), if refractory situations occur. The flexibil-ity in the base of operations as well as strategic changes are
critical to the application of the “hybrid” CTO PCI tech-
nique. We define the “hybrid” approach to CTO PCI, as
the approach that focuses on opening the occluded vessel,
using all feasible techniques (antegrade, retrograde, true-to-
true lumen crossing or re-entry) in the most safe, effective,
and efficient way.
Anatomy Dictates Initial Strategy
In the proposed algorithm, 4 angiographic characteristics
determine the initial procedural approach in patients having
CTO PCI:
1. Proximal cap location and morphology. This charac-
teristic refers to the ability to unambiguously localize
the entry point to the CTO lesion by angiography
and/or intravascular ultrasound and to be able to
properly engage the lesion considering bridging col-
laterals, as well as side branches, with appropriate
wire/device support (which can be complicated in
ostial locations).
2. Lesion length. Lesions are dichotomized to 20
versus 20 mm. CTO PCI on lesions 20 mm in
length tends to have lower success rates and longer
procedure times using standard antegrade wire escala-
tion (22), and may be best approached with early
adoption of alternative techniques, such as primary
antegrade dissection and re-entry, or retrograde tech-
niques. As noted in the previous text, in most cases,
this characteristic can only be accurately assessed by
using dual injections.
3. Target coronary vessel at the distal cap. This refers to
the size of the lumen, to the presence of significant
side branches, to the relative angiographic health of
the vessel at the reconstitution point, and importantly,
to the ability to adequately angiographically visualize
this segment.
4. Size and suitability of collateral circulation for retro-
grade techniques. Optimal collateral vessels for retro-
grade CTO PCI are sourced from a healthy (or
repaired) donor vessel, can be easily accessed with
wires and microcatheters, have minimal tortuosity, are
not the only source of flow to the CTO segment (with
risk for intraprocedural ischemia), and enter the CTO
vessel well beyond the distal cap. More favorable
collateral circulation characteristics lower the barriers
to utilizing retrograde techniques as an initial strategy
or early crossover strategy.
Device Platforms to Support CTO PCI
We favor a selected device portfolio to support coronary
CTO PCI to streamline decision trees, develop operator
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371device-specific expertise, and manage catheterization labo-
ratory and procedure costs. We do recognize the utility of
other wires and devices, as well as novel technologies
currently in development, but the following support most of
our current PCI procedures:
Four-wire strategy:
1. A hydrophilic and/or polymer-jacket 0.014-inch
guidewire, low gram-force, with tapered 0.009-inch
tip, for antegrade microchannel or soft tissue probing
and also for knuckle techniques. Examples include the
Fielder XT wire (Asahi Intecc, Nagoya, Japan) and
Runthrough taper wire (Terumo Corporation, Tokyo,
Japan).
2. A nontapered, polymer-jacket hydrophilic 0.014-inch
guidewire for collateral channel crossing in retrograde
procedures. Examples include the Fielder FC wire
(Asahi Intecc) and Pilot 50 wire (Abbott Vascular,
Santa Clara, California).
3. A moderately high–gram-force (4 to 6 g), polymer-
jacket, nontapered 0.014-inch guidewire for complex
lesion crossing, long lesions, knuckle technique, and
dissection/re-entry, such as the Pilot 200 guidewire
(Abbott Vascular). This wire is particularly useful for
long lesions and complex lesions, and performs well in
very tortuous segments with an ambiguous course.
4. A high–gram-force 0.014-inch guidewire, with a
tapered 0.009-inch nonjacketed tip for penetration
techniques, cap puncture, complex lesion crossing, and
lumen re-entry techniques. An example is the Confi-
anza Pro 12 wire (Asahi Intecc). This wire and similar
devices are best used when the vessel pathway and
location target coronary segment are well understood.
Guidewire selection and utilization is independent of
whether an antegrade or retrograde approach is used. Most
wires should be shaped by inserting the wire through an
introducer tool and placing a shallow 30° to 45° bend no
more than 1 mm from the tip. Occasionally, a secondary
bend is required to allow for proper orientation in the vessel.
Finally, a more acute bend, 2 to 3 mm from the tip, may be
required for high–gram-force wires when wire-based lumen
re-entry is contemplated. Coronary guidewires commonly
used for CTO PCI are listed in Table 1.
Microcatheters:
1. Corsair microcatheter (Asahi Intecc). This is a 2.7-F
catheter with a lubricious outer coating, a bidirectional
wire braiding for torque transmission, and an inner
polymer lumen with soft tip for optimal wire control.
At present, this device is unique in providing a reliable
platform to cross collateral channels and provides the
primary basis for conventional retrograde procedures
(23). This microcatheter can also be used in the
antegrade direction for wire support and exchange aswell as lesion crossing, although we usually employ
smaller outer diameter microcatheters for these pur-
poses. The Corsair catheter is advanced by rotation in
either direction. The Corsair should not be over-
rotated (10 consecutive turns without release) as
over-rotation could cause catheter kinking. Contrast
can be injected through the Corsair for distal vessel
visualization, but the catheter should subsequently be
flushed to minimize the risk for guidewire “stickiness”
and entrapment.
2. Small outer diameter, over-the-wire (OTW) micro-
catheters. Examples include the Finecross (Terumo
Corporation) and Quick-Cross (Spectranetics Corpo-
ration, Colorado Springs, Colorado) catheter for wire
support and exchange.
3. Small OTW balloons for wire support and exchange.
4. Tornus microcatheter (Asahi Intecc). This is a braided-
wire mesh OTW microcatheter with left-handed thread
allowing for channel preparation and lesion crossing in
resistant occlusions. The Tornus is advanced using coun-
terclockwise rotation and removed using clockwise rota-
tion. A coronary guidewire should remain within the
Tornus inner lumen during manipulations, and over-
rotation should be avoided to minimize the risk of
kinking. Contrast injections should not be performed
through the Tornus, as the contrast escapes through the
wire braid and does not reach the catheter tip.
Lesion crossing and lumen re-entry technologies:
1. CrossBoss catheter (BridgePoint Medical, Plymouth,
Minnesota). This is a metal OTW microcatheter with
a rounded tip to prevent vessel exit (24). This device is
rotated rapidly, in either direction, using a “fast spin”
technique (rapid rotation of the catheter using both
hands) and can advance forward through a CTO
without the wire in the lead. If a subintimal/subad-
ventitial position is obtained beside the true lumen,
re-entry is performed.
2. Stingray balloon and Stingray guidewire systems
(BridgePoint Medical). The Stingray balloon is a
1-mm flat balloon with 3 exit ports connected to the
same guidewire lumen (24). The distal exit port is used
to place the balloon in position. The other 2 ports are
180° opposed, so that when inflated, 1 is oriented to the
lumen and the other toward the adventitia. Using fluo-
roscopy for directional orientation, the Stingray guide-
wire (a 0.014-inch high–gram-force guidewire with a
distal tapered “probe” to grab tissue) is used to penetrate
the distal true lumen and gain guidewire position.
Safety devices: CTO PCI catheterization laboratories
should be equipped with a selection of covered stents (25),
embolization coils and delivery systems, pericardiocentesis
trays to manage perforation (26), and thrombectomy devices
s coron
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372to manage thrombotic complications. Hemodynamic sup-
port system availability is a prerequisite as well.
Initial Strategy—Algorithm
All cases are planned as previously discussed in anticipa-
tion of both antegrade and retrograde approaches (the
so-called “hybrid” procedure). The initial directional strategy
of antegrade or retrograde is dependent on the anatomy
confirmed by dual angiography as described with 4 primary
variables considered: 1) ability to identify and safely and
effectively engage the proximal cap; 2) lesion length; 3) signif-
icant branches, size and quality of the target at the distal cap;
and 4) suitability and anticipated ease of retrograde “interven-
tional” collaterals. The goal is to safely and efficiently recanalize
the ischemic bed and provide a “quality result” while maintain-
ing patency of pertinent side branches and outflow vessels.
The combinations of these simple factors can determine
the primary strategy for most procedures (Fig. 1) and
Table 1. Description of Coronary Guidewires Commonly Used in CTO PCI
Wire Category Tip Style Commercial N
Polymer covered Tapered Fielder XT*
Straight (nontapered),
low tip stiffness
Fielder FC*
Whisper LS, MS, ES
Pilot 50
Choice PT Floppy
Straight (nontapered),
high tip stiffness
Pilot 150/200*
Crosswire NT
PT Graphix Intermediate
PT2 Moderate Support
Shinobi
Shinobi Plus
Open coil (no
polymer jacket)
Straight, low tip stiffness SION (hydrophilic)
Tapered, low tip stiffness Cross-it 100XT (0.010-inch)
Runthrough NS tapered (0.00
Tapered, high tip stiffness,
hydrophilic coating
Conﬁanza Pro 9, 12* (0.009-in
PROGRESS 140T, 200T (0.010
Persuader 9 (0.011-inch)
ProVia 9, 12 (0.009-inch)
Straight tip, high tip
stiffness
MiracleBros 3, 4.5, 6
MiracleBros 12
PROGRESS 40, 80, 120
Persuader 3 and 6 (hydrophi
Provia 3, 6 (hydrophilic and -
Tapered, high tip stiffness,
hydrophobic coating
Conﬁanza 9 (hydrophobic)
Persuader 9 (hydrophobic)
ProVia 9, 12 (hydrophobic)
Externalization wires Viper*
RG3
RotaWire Floppy and Extra S
*Most commonly used guidewires.
CTO chronic total occlusion; LaST limited antegrade subintimal tracking; PCI percutaneouidentify subsequent secondary and tertiary bailout tech-niques, should the primary strategy fail. In summary, short
lesions (20 mm) with clearly identified proximal caps and
good distal vessel targets are initially approached with an
antegrade wire escalation strategy. A lesion length 20 mm
has been identified as a predictor of rapid CTO crossing in
the Japan CTO Registry (Multicenter CTO Registry in
Japan) (22). Longer and complex lesions with clearly iden-
tified proximal caps and distal target favor a primary
dissection re-entry approach. Other complex lesions with
poor distal targets or ambiguous access points may favor an
initial retrograde approach. The threshold for dissection/re-
entry or retrograde technique as an initial strategy is lowered
in reattempt procedures.
General Considerations for Strategic Changes
and Procedural Efficiency
The new, hybrid CTO PCI strategy places emphasis, not
only on procedural success, but also on procedural efficiency,
Tip Stiffness Manufacturer Properties
1.2 g Asahi Intecc Frontline wire for antegrade
crossing. Can also be
used for creating knuckle
wire and for retrograde
crossing
1.6 g
0.8, 1.0, 1.2 g
1.5 g
2.1 g
Asahi Intecc
Abbott Vascular
Abbott Vascular
Boston Scientiﬁc
Used to cross through
collateral vessels during
the retrograde approach
2.7 g/4.1 g
7.7 g
1.7 g
2.9 g
7.0 g
6.8 g
Abbott Vascular
Terumo
Boston Scientiﬁc
Boston Scientiﬁc
Cordis
Cordis
Antegrade crossing,
especially when the
course of the occluded
vessel is unclear. Also
useful for knuckle wire
formation and for re-
entry into true lumen
during LaST technique
0.8 Asahi Intecc
)
1.7 g
1.0 g
Abbott Vascular
Terumo
0.009-inch)
9.3, 12.4 g
12.5, 13.3 g
9.1 g
11.8, 13.5 g
Asahi Intecc
Abbott Vascular
Medtronic
Medtronic
Antegrade crossing when
vessel course known
-phobic)
)
3.9, 4.4, 8.8 g
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5.5, 9.7, 13.9 g
5.1, 8.0 g
8.3, 9.1 g
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Asahi Intecc
Abbott Vascular
Medtronic
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Antegrade crossing when
vessel course is known
8.6 g
9.1 g
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vessel course is known
3.6 g CSI
Asahi Intecc
Boston Scientiﬁc
335 cm in length
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325 cm in length
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373possible period and using the least amount of radiation,
contrast, and equipment. The optimal techniques and tech-
nologies are applied during the specific time of the proce-
dure when they are most likely to be effective. The practical
ramifications of this method are that changes of strategy
should occur very early, and often cycle rapidly, to maximize
the likelihood of early successful crossing. Far too often in
conventional CTO PCI, standard strategies are pursued
beyond the point of diminishing return, and bailout tech-
niques are applied when their utility is greatly reduced. An
intended by-product of the hybrid CTO PCI approach is to
reduce procedure time, patient and staff radiation exposure,
and contrast utilization. Although there are no universally
accepted time limits for each of the steps described in the
algorithm (Fig. 1), the recommendation is to stop pursuing
a technique that has not resulted in any significant progress
during a reasonable period. At this point, which is sooner
than traditional PCI, a different technique (such as new
guidewire, new microcatheter, the retrograde approach, and
so on) should be tried. Generally, no more than 5 to 10 min
should be spent in a stagnant mode without minor or major
technique adjustments being made.
Careful attention to fluoroscopy use throughout the case
is important to minimize the risks associated with radiation
exposure. Use of 5-Gy air kerma dose can lead to skin
injury, and 10 Gy significantly increase this possibility,
herefore the procedure should usually be stopped before
xceeding 10 Gy, unless lesion crossing has occurred and
ittle extra time is needed to complete the procedure (27).
Figure 1. Algorithm for Crossing CTOs
The algorithm starts with dual coronary injection (box 1) to allow assessment
grade (boxes 3 to 5) or primary retrograde (box 6) strategy. Strategy change
occlusion; LaST  limited antegrade subintimal tracking.Minimizing fluoroscopy time, routine utilization of non-magnified viewing, decreasing frame rate, coning, fluoros-
copy storage (in lieu of cine acquisition), and image inten-
sifier positional adjustment/rotation can limit skin exposure
to radiation at each entry point (27). Radiation dosing,
monitored closely during the procedure, is a pre-eminent
factor in strategic intraprocedural strategy changes in addi-
tion to case time and lack of progress.
Unfractionated heparin is the anticoagulation of choice
for CTO PCI, as it can be reversed in case of significant
perforation. At the present time, we strongly discourage the
use of bivalirudin, low-molecular-weight heparin, or glyco-
protein IIb/IIIa inhibitors. Finally, the contrast load admin-
istered should be monitored closely during the procedure,
and pre-procedural hydration is encouraged.
Hybrid Techniques
The technical executions within the hybrid CTO PCI
procedure are wire escalation (similar in either antegrade or
retrograde direction) and dissection/re-entry (Stingray de-
vice or wire [the LaST technique] in antegrade direction
and CART or reverse CART in retrograde direction).
Wire Escalation
As noted in Figure 1, this is the initial strategy of choice in
a 20-mm CTO with reasonably definable proximal cap
and distal target. The initial wire to probe the CTO is
typically a low–gram-force, polymer-jacket wire, unless the
proximal cap is clearly blunt, calcified, or ambiguous. We
eral angiographic parameters (box 2) and allow selection of a primary ante-
ade (box 7), depending on the progress of the case. CTO  chronic totalof sev
s are mfavor a tapered wire in the antegrade direction (such as the
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374Fielder XT, Asahi Intecc) and nontapered in the retrograde
direction (as this wire is available having been used to cross
the collateral vessels). The lesion is probed with a soft
sliding technique, with soft drilling and emphasis in keeping
the tip free and with appropriate shape on fluoroscopy. If
the wire buckles, the OTW support catheter is advanced to
support column strength at the tip. Probing is again
performed. If the wire demonstrates lack of progress, goes
offline, or buckles, it is determined to be ineffective and wire
exchange is performed. In our experience, this series of
maneuvers can be accomplished within a few minutes and,
therefore, initial probing is not intended to be an extensive,
time-consuming effort. The subsequent wire is determined
by lesion characteristics. If the crossing distance is long,
uncertain, or tortuous, we favor a moderately high–gram-
force, nontapered, polymer-jacket wire, such as the Pilot
200 (Abbott Vascular). This platform is optimal for tracking
the vessel structure and rarely exits the wall of the CTO
segment. If the lesion distance is short and its course well
understood, a stiff, tapered penetration wire (such as the
Confianza Pro 12, Asahi Intecc) is chosen, employing a
focused, directional penetration technique. Each of these
wire platforms will serve as the subsequent bailout for the
other. If the wires fail to progress (Fig. 2, Online Videos 1,
2, 3, 4, and 5), or enter the subintimal space (remaining
within the vessel wall), conversion to dissection re-entry
techniques is performed.
Dissection Re-Entry Techniques
Antegrade dissection. Antegrade dissection occurs when a
uidewire or crossing catheter advances antegradely within
he subintimal space (inside the vessel wall but outside the
imits of what formerly was the true lumen). This can be
chieved by using a CrossBoss catheter (BridgePoint Med-
cal) or a knuckle wire technique (28–30). In the latter
pproach, a looped, polymer-jacket wire (knuckle wire) is
dvanced without rotation in the direction of the distal
TO segment. Typically, the leading end of the knuckle
ire will be the stiff-to-floppy transition point near the
ibbon/coils of the guidewire. Although it may seem coun-
erintuitive, this approach has been tested to be a much safer
ay to advance through the course of an ambiguous CTO
egment than with stiffer guidewires. The reason relates to
dventitial distensibility. Blunt objects can be accommo-
ated within the adventitia without perforation. Stiff guide-
ires, by contrast, may penetrate the adventitia because
ore force is directed to the relatively small area of the tip.
n addition, the knuckled wire is less likely to be directed
nto and subsequently perforate small branches. It is impor-
ant to manage the size of the knuckle with a diameter that
atches the expected vessel size and ensure that it extends
ongitudinally within the vessel structure. This knuckle wire
echnique, or alternatively, the blunt-tipped CrossBossatheter (BridgePoint Medical) are effective ways to move
orward within the CTO segment when wire methods are
onsidered inefficient or less safe. The CrossBoss catheter
as the advantage of creating a smaller subadventitial space,
hich is less likely to accumulate blood. Such features can
acilitate use of the Stingray system, as false lumen hema-
oma may decrease vessel wall contact with the Stingray
alloon and wire and thus hinder re-entry attempts. In
ddition, a dissection/hematoma that is too large can
mpinge upon the true lumen, making re-entry more
ifficult.
Re-entry techniques. After subintimal crossing, 2 primary
ethods can be used for re-entering the lumen: 1) wire-
ased (LaST method) (31); or 2) device-based (Stingray
alloon and guidewire, BridgePoint Medical).
The LaST Method
When antegrade wiring fails and Stingray-based re-entry or
retrograde techniques are not an option or have failed, and
alternate bailout strategy is the LaST technique. Once a
microcatheter is positioned near the re-entry point, the
knuckle wire is withdrawn and a stiff polymer jacket and/or
a stiff tapered guidewire is inserted and directed into the
distal true lumen (31).
The Stingray System
The Stingray system (BridgePoint Medical) consists of a
balloon that assumes a flat shape when inflated at 3 to 4
atm, and a guidewire with an extreme 0.0025-inch tapered
distal tip (24,30). The Stingray balloon has 2 exit ports that
are diametrically opposed. Each port is proximal to a
radio-opaque marker. The Stingray guidewire is advanced
through the luminal exit port of the Stingray balloon until
the wire crosses into the true lumen, which needs to be
confirmed by contralateral injection, or by visualization
though ipsilateral collaterals (Fig. 3, Online Videos 6, 7, 8,
9, 10, and 11). Sometimes the Stingray wire may fail to
advance into the distal true lumen despite effective re-entry,
as it tends to catch tissue and re-exit in a false channel. In
such cases, the Stingray wire should be exchanged for a
plastic-jacket guidewire, which can be readvanced into the
same puncture hole created by the Stingray guidewire, and
then more easily positioned in the distal vessel. This later
technique has emerged as a very effective and efficient
variant to avoid further damage to the distal vessel (“stick
and switch” technique), especially when diseased and/or
negatively remodeled.
Retrograde Dissection Re-Entry
Reverse CART. The most commonly used method to con-
nect the proximal and distal true lumen in retrograde CTO
PCI procedures if retrograde true lumen crossing attempts
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375Figure 2. Complex Antegrade and Retrograde Intervention of a Right Coronary Artery CTO
Bilateral coronary angiography demonstrating a proximal right coronary artery chronic total occlusion (CTO) due to in-stent restenosis (arrow, A) (see Online
Video 1). The right posterior descending coronary artery ﬁlled by septal collaterals from the left anterior descending coronary artery (B) (see Online Video 2).
Angiographic characteristics included deﬁned proximal cap, good distal target, long lesion length, and appropriate retrograde “interventional collaterals.” Ante-
grade crossing attempts using a CrossBoss catheter (BridgePoint Medical) (arrow, C) and antegrade wire escalation failed. A Corsair microcatheter (arrow, D)
(see Online Video 3) was advanced retrograde via a septal collateral to the mid right coronary artery over a nontapered polymer-jacket guidewire, but attempts
to cross the occlusion retrograde failed (E). Repeat antegrade crossing attempts with a moderately stiff, nontapered polymer-jacket wire (Pilot 200 wire, Abbott
Vascular, Santa Clara, California) using limited subintimal tracking technique were successful in subintimal advancement of the wire (arrow, F) (see Online Video
4). After a GuideLiner catheter (Vascular Solutions, Minneapolis, Minnesota) (arrowhead, G) was advanced into the proximal right coronary artery a Conﬁanza
Pro 12 wire (Abbott Vascular) (arrow, G) successfully crossed the occlusion into the distal true lumen. After implantation of multiple drug-eluting stents an
excellent angiographic result was achieved (H) (see Online Video 5). This case highlights the importance of multiple modiﬁcations in the procedural plan (I), and
“switching” strategies to be adaptive during chronic total occlusion percutaneous coronary interventions. LaST  limited antegrade subintimal tracking.
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376are unsuccessful is the reverse CART (17,23,32) technique
(Fig. 4, Online Videos 12, 13, 14, 15, 16, and 17). In this
method, a microcatheter (often Corsair microcatheter,
Figure 3. Antegrade Crossing—Provisional Re-Entry
Coronary angiography demonstrating a chronic total occlusion of the mid left
teristics included well-visualized proximal cap, good distal target, and lesion le
sota) was advanced to the proximal cap (arrow, B) (see Online Video 7). With
mid left anterior descending coronary artery (arrow, C) (see Online Video 8). T
(arrows D) (see Online Video 9), located adjacent to the true lumen (arrowhe
into the distal true lumen. Angiography after predilation showed (as expected
multiple drug-eluting stents, an excellent angiographic result was achieved (GAsahi Intecc) is placed across a collateral vessel from thedonor artery and into the CTO segment over a guidewire.
An antegrade wire is advanced into the CTO segment alone
or in combination with a crossing catheter or a balloon. An
or descending artery (arrows, A) (see Online Video 6). Angiographic charac-
20 mm (H). A CrossBoss catheter (BridgePoint Medical, Plymouth, Minne-
st spin technique, the catheter crossed the occlusion subintimally into the
ossBoss catheter was exchanged for a Stingray balloon (BridgePoint Medical)
). A Stingray guidewire (arrow, E) (see Online Video 10) successfully crossed
ction at the area of subintimal crossing (arrows, F). After implantation of
Online Video 11).anteri
ngth
the fa
he Cr
ads, D
) disse
) (seeangioplasty balloon is approximated over the antegrade wire
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377Figure 4. Primary Retrograde PCI to a Right Coronary Artery CTO
Dual coronary angiography demonstrating a chronic total occlusion (CTO) of the proximal right coronary artery (arrows, A and B) (see Online Videos 12 and 13)
with distal ﬁlling via collaterals from the left anterior descending coronary artery. The angiographic characterization was poorly identiﬁed proximal cap, long
lesion, diffusely diseased distal target, and good interventional collaterals (H). A Corsair microcatheter (Asahi Intecc, Nagoya, Japan) (arrow, C) (see Online Video
14) was advanced retrogradely via a septal collateral over a polymer-jacket, nontapered guidewire, to the distal right coronary artery. A second Corsair micro-
catheter (arrowhead, C) was advanced antegradely to the mid right coronary artery. After antegrade insertion of a GuideLiner catheter (Vascular Solutions, Min-
neapolis, Minnesota) (arrowhead, D) (see Online Video 15), a 2.5  20-mm balloon was inﬂated over the antegrade guidewire in the mid right coronary artery
(arrow, D), and reverse controlled antegrade and retrograde tracking and dissection was performed, followed by successful advancement of a retrograde
Pilot 200 guidewire (Abbott Vascular, Santa Clara, California) (E) (see Online Video 16) into the antegrade GuideLiner (arrowhead, E). A ViperWire Advance
335-cm guidewire (Cardiovascular Systems, St. Paul, Minnesota) was externalized followed by pre-dilation of the right coronary artery (F) and implantation of
multiple drug-eluting stents, restoring Thrombolysis In Myocardial Infarction ﬂow grade 3 antegrade ﬂow (G) (see Online Video 17). LaST  limited antegrade
subintimal tracking; PCI  percutaneous coronary intervention.
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378adjacent to the retrograde microcatheter and inflated. Be-
fore this, the antegrade and retrograde systems may reside in
the same subadventitial space, within the CTO plaque, or in
combination. However, if both systems are within the
essel structure, relative locations become less material
ecause balloon angioplasty creates a connection between
he 2 spaces. A retrograde wire can then be passed into
he proximal vessel, and wire externalization (which
nvolves externalizing the tip of a long, 300-cm or more
uidewire at the antegrade hemostatic valve) or retro-
rade balloon angioplasty can be performed. The Viper-
ire Advance guidewire (CSI, St. Paul, Minnesota) is
35 cm long, provides excellent support, and is currently
he preferred wire for externalization (32,33) where
vailable. Intravascular ultrasonography guidance can fa-
ilitate performance of reverse CART, by allowing selec-
ion of the appropriate balloon size (34). In certain
ircumstances, the classic CART technique can be per-
ormed with retrograde dilation with a Corsair catheter
r OTW balloon and advancement of an antegrade wire
o the distal true lumen. We recently published detailed
ractical descriptions of the retrograde technique (32,33).
onclusions
The presented procedural algorithm can provide a useful
working and training framework for operators perform-
ing CTO PCI and may help increase attempt and success
rates, improve efficiency, and minimize complications.
Further studies are needed to validate this approach.
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